Amneal Pharmaceuticals Inc (AMRX)
5.94
+0.07
(+1.19%)
USD |
NASDAQ |
Apr 29, 16:00
5.94
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Max Drawdown (5Y): 94.77% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 94.77% |
| February 29, 2024 | 94.77% |
| January 31, 2024 | 94.77% |
| December 31, 2023 | 94.77% |
| November 30, 2023 | 94.77% |
| October 31, 2023 | 94.77% |
| September 30, 2023 | 94.77% |
| August 31, 2023 | 94.77% |
| July 31, 2023 | 94.77% |
| June 30, 2023 | 94.77% |
| May 31, 2023 | 94.77% |
| April 30, 2023 | 94.77% |
| March 31, 2023 | 94.77% |
| February 28, 2023 | 91.92% |
| January 31, 2023 | 91.92% |
| December 31, 2022 | 91.92% |
| November 30, 2022 | 91.92% |
| October 31, 2022 | 91.92% |
| September 30, 2022 | 91.68% |
| August 31, 2022 | 91.06% |
| July 31, 2022 | 90.56% |
| June 30, 2022 | 90.56% |
| May 31, 2022 | 90.56% |
| April 30, 2022 | 90.56% |
| March 31, 2022 | 90.56% |
| Date | Value |
|---|---|
| February 28, 2022 | 90.56% |
| January 31, 2022 | 90.56% |
| December 31, 2021 | 90.56% |
| November 30, 2021 | 90.56% |
| October 31, 2021 | 90.56% |
| September 30, 2021 | 90.56% |
| August 31, 2021 | 90.56% |
| July 31, 2021 | 90.56% |
| June 30, 2021 | 90.56% |
| May 31, 2021 | 90.56% |
| April 30, 2021 | 90.56% |
| March 31, 2021 | 90.56% |
| February 28, 2021 | 90.56% |
| January 31, 2021 | 90.56% |
| December 31, 2020 | 90.56% |
| November 30, 2020 | 90.56% |
| October 31, 2020 | 90.56% |
| September 30, 2020 | 90.56% |
| August 31, 2020 | 90.56% |
| July 31, 2020 | 90.56% |
| June 30, 2020 | 90.56% |
| May 31, 2020 | 90.56% |
| April 30, 2020 | 90.56% |
| March 31, 2020 | 90.56% |
| February 29, 2020 | 90.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
51.09%
Minimum
Apr 2019
94.77%
Maximum
Mar 2023
90.24%
Average
90.56%
Median
Aug 2019
Max Drawdown (5Y) Benchmarks
| Fate Therapeutics Inc | 98.59% |
| Ocular Therapeutix Inc | 94.06% |
| Editas Medicine Inc | 93.10% |
| AnaptysBio Inc | 92.08% |
| Stoke Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.99 |
| Beta (5Y) | 1.330 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 68.84% |
| Historical Sharpe Ratio (5Y) | -0.256 |
| Historical Sortino (5Y) | -0.4125 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.62% |